Pharmacogenetics of cystic fibrosis treatment. - Wikidata - wikimedia - TriplyDB

Pharmacogenetics of cystic fibrosis treatment.

Pharmacogenetics of cystic fibrosis treatment.

http://www.wikidata.org/entity/Q38918082

about

Modulation of TMEM16A channel activity by the von Willebrand factor type A (VWA) domain of the calcium-activated chloride channel regulator 1 (CLCA1).Special considerations for the treatment of pulmonary exacerbations in children with cystic fibrosis.

P2860

Q38707029-381AE259-A950-42B9-98BE-725CE69B564D Q38975705-752354F5-D985-4D67-9BE9-852B47ED76FB

P2860

Pharmacogenetics of cystic fibrosis treatment.

http://www.wikidata.org/entity/Q38918082

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Pharmacogenetics of cystic fibrosis treatment.

@en

type

label

Pharmacogenetics of cystic fibrosis treatment.

@en

prefLabel

Pharmacogenetics of cystic fibrosis treatment.

@en

P1433

Q38918082-66FA6FF0-B1D6-48D3-8227-1EF49FB8ED52

P1476

Q38918082-99119460-7848-4291-BBC4-9FB18A2FEAB7

P2093

Q38918082-7229F963-BE38-4D78-84D9-A66B47B793AA

Q38918082-BB0C7D22-EA36-4FBF-A216-CEB6667CEB00

P2860

Q38918082-004319D9-F896-44E7-8012-07AC4CA951BC

Q38918082-00C482BE-D0B5-4511-B1D6-FA8AFEB0C3E7

Q38918082-00D7E159-30D6-471D-9082-BE40550663CB

Q38918082-0B0E852B-8084-4177-AE3B-3C1CC08E2036

Q38918082-0BF930E1-9805-4CB9-B78D-4A001A636DA6

Q38918082-15A2C070-FAD4-4882-8DC3-6933A15383AA

Q38918082-2A3727A7-3C46-45C3-AB52-103C1589BB90

Q38918082-2A968212-EC6F-4A19-89D2-E93BB7DEFFF2

Q38918082-32675FD5-7D70-45D6-B8B1-14BD664D562A

Q38918082-3444152C-5662-4913-9B0D-BD64C5FD017B

P304

Q38918082-5B9D2C96-CE71-4175-AC48-7385412362C0

P31

Q38918082-70791A20-AD94-4A14-B59F-EF3148B2511E

P356

Q38918082-BB3958E1-99D0-4BB0-B4AC-865DC7324CB9

P433

Q38918082-E3F6B572-C66E-4EA8-A147-7F82356DC55B

P478

Q38918082-CFE34458-7D15-43E9-A9EA-9A1062AD19B6

P577

Q38918082-E87E5B01-0342-4720-9355-6BA390C9175E

P698

Q38918082-1388B679-19C8-4AB9-B3D9-704288F962C8

P921

Q38918082-54F60688-D5AD-457C-8949-33B1854E6F29

P356

P1433

Pharmacogenomics

P1476

Pharmacogenetics of cystic fibrosis treatment.

@en

P2093

Edward F McKone

http://www.w3.org/2001/XMLSchema#string

Suzanne C Carter

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the cystic fibrosis gene: chromosome walking and jumping

Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation

Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770

Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report

Cystic fibrosis

Cystic fibrosis therapeutics: the road ahead

Origins of cystic fibrosis lung disease

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening

CYSTIC FIBROSIS OF THE PANCREAS AND ITS RELATION TO CELIAC DISEASE

P304

1453-1463

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.16.25

http://www.w3.org/2001/XMLSchema#string

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27490265

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis